1.270USD-3.05%Mkt Cap: 51.92M USDP/E: —Last update: 2026-05-29
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap51.92M USD
Enterprise Value45.09M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-630.78M USD
Revenue/Share—
Last Price1.270 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS66987P3001
Valuation
P/E (Trailing)—
P/E (Forward)-2.38
PEG—
EV/EBITDA-5.95
EV/Revenue—
P/S—
P/B—
EPS (TTM)-28.50
EPS (Forward)-0.82
52W Range
1.1100% of range99.75
52W High99.75 USD
52W Low1.110 USD
Profitability
Gross Margin0.00%
Oper. Margin350.10%
EBITDA Margin0.00%
Profit Margin0.00%
ROE99.84%
ROA-6981.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.43M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-9.51%
Net Debt-7.18M USD
Net Debt/EBITDA0.95
Balance Sheet
Debt/Equity-0.00
Current Ratio7.60
Quick Ratio6.97
Book Value/Sh-0.9190 USD
Cash/Share0.2990 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 30, 2025
Pay Date—
Splits
Last Split1:5
Split DateFeb 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.26.63M
Float2.62M
Insiders90.14%
Institutions5.34%
Short Interest
Short Ratio0.7d
Short % Float9.79%
Short % Out.1.28%
Shares Short333.12K
Short (prev mo.)767.85K
Technical
SMA 502.162 (-41.3%)
SMA 20010.21 (-87.6%)
Beta0.16
S&P 52W Chg27.94%
Avg Vol (30d)129.17K
Avg Vol (10d)294.92K
Technical Indicators
RSI (14)37.9
MACD-0.0957
MACD Signal-0.0860
MACD Hist.-0.0096
BB Upper1.822 USD
BB Middle1.508 USD
BB Lower1.193 USD
BB Width41.67%
ATR (14)0.1869 USD
Vol Ratio (20d)0.82x